Integrative core framework: umbilical cord mesenchymal stem cells
Our clinical framework utilizes umbilical cord‑derived mesenchymal stem cells (UC‑MSCs) for their immunomodulatory and paracrine signaling properties. Administered via minimally invasive techniques, the objective is to support thyroid tissue integrity and influence the autoimmune environment in Hashimoto's thyroiditis. This adjunctive approach is performed as part of a comprehensive functional medicine strategy, not as a standalone cure or replacement for thyroid hormone therapy.
Supportive physical therapy addresses musculoskeletal symptoms often associated with autoimmune thyroiditis, improving range of motion and reducing discomfort. Nutritional medicine provides targeted, evidence‑based dietary guidance to reduce inflammatory load and correct common nutrient depletions (selenium, zinc, vitamin D). (PubMed: MSC immunomodulation in autoimmune thyroiditis)
Mechanisms of Action: MSC Support in Hashimoto's
Immunomodulation
MSCs secrete anti‑inflammatory cytokines (IL‑10, TGF‑β) that shift macrophages from pro‑inflammatory (M1) to regulatory (M2) phenotypes, reducing lymphocyte infiltration into thyroid tissue and promoting a tolerogenic immune environment.
Paracrine Signaling
Through paracrine signaling, MSCs release growth factors (HGF, VEGF, FGF) and extracellular vesicles that modulate the local tissue microenvironment, reduce oxidative stress, and support cellular survival in thyroid tissue.
Autoimmune Regulation
MSCs reduce Th17 cell activity, promote regulatory T‑cell (Treg) expansion, and modulate autoantibody production (anti‑TPO, anti‑thyroglobulin), helping to rebalance the autoimmune response characteristic of Hashimoto's.
Hashimoto's supportive guide
Download the Patient's Guide: Understanding umbilical cord MSCs, physical therapy integration & nutritional foundations in Hashimoto's thyroiditis. Objective, verifiable resource.
Supportive therapies
Physical therapy focuses on functional optimization for musculoskeletal symptoms common in Hashimoto's (myalgias, joint stiffness). Nutritional medicine evaluates micronutrient status (selenium, zinc, vitamin D) and designs anti‑inflammatory dietary patterns. Both are administered as complementary modalities to the core adjunctive MSC framework.
Learn MoreMinimally invasive techniques
Intravenous and targeted administration of umbilical cord MSCs. No surgical incisions. Procedures are performed in a controlled environment with emphasis on patient comfort and safety.
Meet Our Doctors →Important clinical note: This adjunctive supportive approach is not a replacement for standard Hashimoto's treatments (such as levothyroxine replacement therapy, regular thyroid function monitoring, or conventional medical management). Patients should continue those treatments under the direction of their prescribing physician.
Medically reviewed by Dr. Guillermo Quezada, MD – May 2026 (regenerative medicine specialist) | Content reviewed as of March 2026
MSC therapy for Hashimoto's thyroiditis is not approved by the U.S. FDA, Mexican COFEPRIS (for this indication), or any other regulatory agency. It is considered an adjunctive, experimental procedure.
Costs are discussed only after a consultation.
Begin Your Consultation Journey
Complete your evaluation request. Our regenerative specialists provide objective guidance regarding Hashimoto's supportive protocols.
Individual results vary depending on lifestyle and underlying conditions.
Request a Hashimoto's Consultation
Our regenerative medicine team is ready to evaluate your needs
Individual results vary depending on lifestyle and underlying conditions.